Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity.

Yang J, Wan L, Chen H, Li S, Zhou Y

Open source

DOI
10.3389/fimmu.2026.1834919
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1834919,
  title = {Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity.},
  author = {Yang J and Wan L and Chen H and Li S and Zhou Y},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1834919},
  url = {https://doi.org/10.3389/fimmu.2026.1834919}
}

RIS

TY  - JOUR
TI  - Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity.
AU  - Yang J
AU  - Wan L
AU  - Chen H
AU  - Li S
AU  - Zhou Y
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1834919
UR  - https://doi.org/10.3389/fimmu.2026.1834919
ER  - 

APA

J, Y., L, W., H, C., S, L., & Y, Z. (2026). Immunometabolic reprogramming in rheumatoid arthritis: the epitranscriptomic role of N6-methyladenosine in innate and adaptive immunity.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1834919

Source records